Skip to main content
Clinical Trials/NCT02070016
NCT02070016
Withdrawn
N/A

Clinical Applicaitons of Non-Invasive Brain Stimulation for the Treatment of Chronic Pain

Stanford University1 site in 1 countryJanuary 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Low Back Pain
Sponsor
Stanford University
Locations
1
Primary Endpoint
Change in Average Daily Pain
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to test whether non-invasive brain stimulation, such as Transcranial Magnetic Stimulation (TMS) may alleviate pain associated with various chronic pain conditions. We will test various methods of TMS to identify a treatment approach that may reduce the symptoms of chronic pain for the patient.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
October 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sean Mackey

Chief, Division of Pain Medicine

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Patient with Chronic Low Back Pain
  • Meets minimum pain level criteria
  • Ability to perform the experimental Task and Procedures

Exclusion Criteria

  • MRI contraindication if an MRI exam is required per protocol
  • TMS Contraindication
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.

Outcomes

Primary Outcomes

Change in Average Daily Pain

Time Frame: Baseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)

Compared to baseline pain report as provided by Visual Analogue Scale (VAS)

Change in Worst Daily Pain

Time Frame: Baseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)

As compared to baseline worst daily pain report provided on visual analogue scale (VAS)

Study Sites (1)

Loading locations...

Similar Trials